跳至主要内容
临床试验/CTRI/2022/07/044107
CTRI/2022/07/044107已完成未知

Estimation of Soluble urokinase plasminogen activator receptor (Supar) and YKL-40 levels in saliva and serum in generalized periodontitis patients with and without Type 2 Diabetes Mellitus (T2DM).

Bhavana Vunnam0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Age group 35-75 years.
  • 2. Patients who have not received any periodontal treatment in previous six months.
  • 3. Patients diagnosed with T2DM as per American Diabetes Association criteria (2019).
  • 4. Patients with a diagnosis of generalized periodontitis as per World Workshop Classification criteria (2017).

排除标准

  • 1.Smokers and alcoholics.
  • 2.Patients with systemic diseases like hypertension, cardiovascular diseases, rheumatoid arthritis, tumours, autoimmune diseases and renal diseases.
  • 3.Pregnant, lactating females and post menopausal women.
  • 4.Any other systemic disease which can alter the course of periodontal disease.
  • 5.Patients on medications like anti-inflammatory drugs, antibiotics and anti-epileptic drugs in the past 6 months.

研究者

发起方
Bhavana Vunnam

相似试验